Innate Pharma (IPHA) — Cash Flow-to-Debt Ratio
Innate Pharma (IPHA) has a Cash Flow-to-Debt Ratio of -0.28x as of March 2026, meaning its operating cash flow of $-23.40 Million could theoretically repay 0% of its total liabilities ($84.39 Million) in one year. See free cash flow generation of Innate Pharma to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Innate Pharma Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Innate Pharma across 21 annual periods. Also explore Innate Pharma annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Innate Pharma (2005–2025)
Year-by-year debt coverage analysis for Innate Pharma. For market capitalisation and broader financial context, see IPHA market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.60x | $-50.67 Million | $84.39 Million | ▼ -790.1% |
| 2024 | -0.07x | $-6.90 Million | $102.22 Million | ▲ +72.6% |
| 2023 | -0.25x | $-32.56 Million | $132.29 Million | ▼ -97.5% |
| 2022 | -0.12x | $-19.15 Million | $153.71 Million | ▲ +65.9% |
| 2021 | -0.37x | $-58.46 Million | $160.06 Million | ▼ -6.8% |
| 2020 | -0.34x | $-51.81 Million | $151.45 Million | ▼ -280.2% |
| 2019 | 0.19x | $34.92 Million | $183.94 Million | ▲ +265.7% |
| 2018 | -0.11x | $-32.53 Million | $283.98 Million | ▲ +59.7% |
| 2017 | -0.28x | $-48.06 Million | $169.07 Million | ▼ -50.7% |
| 2016 | -0.19x | $-36.85 Million | $195.41 Million | ▼ -121.2% |
| 2015 | 0.89x | $207.91 Million | $233.89 Million | ▲ +178.7% |
| 2014 | -1.13x | $-18.13 Million | $16.06 Million | ▼ -60.5% |
| 2013 | -0.70x | $-10.97 Million | $15.60 Million | ▼ -67.4% |
| 2012 | -0.42x | $-10.47 Million | $24.93 Million | ▼ -208.3% |
| 2011 | 0.39x | $12.99 Million | $33.48 Million | ▲ +141.8% |
| 2010 | -0.93x | $-13.45 Million | $14.49 Million | ▼ -167.3% |
| 2009 | -0.35x | $-5.94 Million | $17.10 Million | ▲ +54.0% |
| 2008 | -0.76x | $-14.74 Million | $19.52 Million | ▼ -10.2% |
| 2007 | -0.69x | $-9.28 Million | $13.55 Million | ▼ -2552.5% |
| 2006 | 0.03x | $360.00K | $12.89 Million | ▲ +101.8% |
| 2005 | -1.54x | $-7.25 Million | $4.70 Million | — |